Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-19-061939

SVP, Finance and CFO sold 59,456 shares at an average $45.67 ($2,715,517)

  • SVP, Finance and CFO acquired 56,254 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cotroneo Pat · SVP, Finance and CFO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-20 Exercise or conversion : show line 1 in the form +18,000 $3.50 $63,000 271,788 D
2019-12-20 Exercise or conversion : show line 2 in the form +21,000 $5.95 $124,950 292,788 D
2019-12-20 Exercise or conversion : show line 3 in the form +17,254 $14.58 $251,477 310,042 D
2019-12-20 Sale : show line 4 in the form −46,727 $45.51 $2,126,546 263,315 D
2019-12-20 Sale : show line 5 in the form −12,729 $46.27 $588,971 250,586 D
Open-market sales · 59,456 sh · avg $45.67 · $2,715,517

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-20 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −18,000 $3.50 2021-06-07 18,000 0 D
2019-12-20 Exercise or conversion : show line 7 in the form Stock Optin (Right to Buy) −21,000 $5.95 2022-06-27 21,000 0 D
2019-12-20 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −17,254 $14.58 2024-03-19 17,254 0 D
Loading xslF345X03/doc4.xml…